Overview

Heart and vascular disease remains the leading contributor to morbidity and mortality among both women and men. While the decrease in mortality among women is well documented, the decline still lags behind that of men, with an alarming tendency towards an increase mortality rate among younger women. Despite statistics that show disease develops on average 7–10 years later in women compared with men, adverse trends in many risk factors among women are of growing concern.

Women also have an increased lifetime prevalence of stroke risk factors, including hypertension, as well as abdominal obesity and metabolic syndrome, especially in middle-aged women. In the United States, 53.5% of the estimated new or recurrent strokes occur among women annually, resulting in more stroke events in women than in men. Cardiovascular disease and stroke impact women differently across race and ethnicity while cultural, educational and economic disparities further complicate prevention efforts like screening and risk factor management, diagnosis, treatment selection and patient compliance or cooperation.

Cardiovascular diseases are the leading cause of death for Hispanic women yet only 34% know that heart disease is their greatest health risk. Hispanic women are likely to develop heart disease 10 years earlier than Caucasian women and are least likely to have a usual source of health medical care. Today only 1 in 8 say that their doctor has ever discussed their risk for heart disease. Cardiovascular diseases are the leading cause of death for African-American women too. Of African-American women ages 20 and older, 48.3% have cardiovascular disease with only 14% believing this to be their greatest health problem. For American Indian or Alaska Native and Asian or Pacific Islander women, heart disease is second only to cancer.

Greater life expectancy for women, together with improvements in primary and secondary prevention of cardiovascular, will lead to a larger proportion of women living with disease. Substantial sex differences in the burden of different manifestations of cardiovascular disease, including coronary heart disease (CHD), stroke, heart failure, and peripheral artery disease, are widely recognized and must be addressed as new research and best practices are developed.

• Target Audience
• Learning Objectives
• Accreditation
• Credit Designation
• Nursing Accreditation
• Faculty
• Program
• Registration
• Location & Lodging
• Ground Transportation & Parking
   

---

Target Audience

 

The goal of this symposium is to educate the primary care physicians for women; obstetricians/gynecologists, internal medicine, family practice, endocrinologists, and nurse practitioners about prevention, early diagnosis and treatment strategies for heart disease in women.

 

Learning Objectives

At the conclusion of this activity, the participant should be able to:

• Cite the identification of cardiac risk factors in women
• Review and clarify current guidelines for prevention, treatment and diagnosis of heart disease and stroke in women.
• Discuss and clarify cardiovascular risk stratification of female patients, which will be used to guide preventative treatment strategies.
• Discuss and implement current and new diagnostic tools and treatment techniques.
• Develop reliable diagnostic techniques that provide guidance to physicians in developing treatment.
• Discuss challenges of healthcare related to cardiovascular treatment and research in women.
• Review treatment and health promotion activities that typically require action from multiple parties, including clinicians, the broader healthcare team, and the system in which health care is delivered, as well as patients.

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

 

Texas Heart Institute designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits^TM. 

 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Accreditation

 

CHI St. Luke’s Health Baylor St. Luke’s Medical Center is an approved provider of continuing nursing education by the Texas Nurses Association – Approver is accredited with distinction, of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Up to 7.33 contact hours will be awarded for successful completion of this activity. To receive a certificate of completion with awarded contact hours, you are required to sign-in at registration, attend the entire program, and return the completed evaluation form.

Faculty

 

 

David Aguilar, MD Adult Cardiology Texas Children’s Hospital Houston, Texas

Eric Boerwinkle, PhD      Dean, UTHealth School of Public Health M. David Low Chair in Public Health Kozmetsky Family Chair in Human Genetics Professor, Center for Human Genetics and Dept. of Epidemiology Associate Director, Human Genome Sequencing Center Baylor College of Medicine Houston, Texas

Karla Campos, MD Cardiology Research Associate Texas Heart Institute Houston, Texas

Briana Costello, MD Cardiology Fellow CHI St. Luke's Health - Baylor St. Luke's Medical Center Houston, Texas

Stephanie Coulter, MD, FACC, FASE  (Program Director) Director, Texas Heart Institute Center for Women’s Heart and Vascular Health Associate Director, Non-Invasive Cardiology Texas Heart Institute; CHI St. Luke’s Health – Baylor St. Luke’s Medical Center Cardiologist, Leachman Cardiology Associates Houston, Texas

R. David Fish, MD Director, Interventional Cardiology Research and Education Texas Heart Institute Houston, Texas

Eduardo Hernandez, MD Director, Interventional Cardiology at the Diagnostic Heart Center CHI St. Luke’s Health - Baylor St. Luke’s Medical Center Texas Heart Institute Houston, Texas

Zvonimir Krajcer, MD Program Director, Peripheral Vascular Interventions CHI St. Luke’s Health - Baylor St. Luke’s Medical Center Texas Heart Institute Houston, Texas

David Kuten, MD Interventional Cardiology Fellow CHI St. Luke's Health - Baylor St. Luke's Medical Center Houston, Texas

Carol Lai, MD Cardiology Fellow CHI St. Luke's Health - Baylor St. Luke's Medical Center Houston, Texas

Gabriel Loor, MD Associate Professor of Surgery, Surgical Director of Lung Transplantation, & Co-Chief Section of Cardiac Surgery CHI St. Luke's Health - Baylor St. Luke's Medical Center Houston, TX

Ali J. Marian, MD Professor and Director, Center for Cardiovascular Genetic Research George and Mary Josephine Hamman Foundation Distinguished Professor in Cardiovascular Research Houston, Texas

Ajith Nair, MD Assistant Professor, Cardiology Baylor College of Medicine Houston, Texas

Emerson Perin, MD, PhD, FACC Director, Clinical Research for Cardiovascular Medicine Medical Director; Stem Cell Center Medical Director, BSLMC Catheterization Lab Texas Heart Institute Houston, Texas

Mehdi Razavi, MD Director, Electrophysiology Clinical Research Texas Heart Institute Associate Professor Baylor College of Medicine Houston, Texas

Tina Shah, MBBS, FACC Director, Cardiology Clinic Site Director, Cardiology Fellowship Michael E. DeBakey Veterans Affairs Medical Center Assistant Professor, Cardiology Baylor College of Medicine Houston, Texas

Renu Virmani, MD, FACC Founder, President and Medical Director, CVPath Institute Clinical Professor; Department of Pathology Georgetown University; University of Maryland-Baltimore; George Washington & Vanderbilt University Former Chairperson; Department of Cardiovascular Pathology Armed Forces Institute of Pathology Gaithersburg, MD

James Willerson, MD, FACC President Emeritus; Texas Heart Institute Houston, Texas

 

Program

 

7:00 am                      Registration & Breakfast

8:00 am                      Welcome
                                  James T. Willerson, MD, FACC
            
8:10 am                      Keynote: Nonatherosclerotic Coronary Disease in Women
                                  Renu Virmani, MD

Session I                     Update on Risk Factors & Prevention

8:55 - 9:15 am            It’s All About the Risk: Lipid Lowering in the Age of Increasing Evidenced Based Choices
                                  Tina Shah, MBBS, FACC

9:15 - 9:35 am            What Do the Guidelines Really Say About Aspirin?
                                  Eduardo Hernandez, MD

9:35 - 9:55 am            Diabetes Combination Regimens: What’s in the Mixed Bag for Women?
                                  David Aguilar, MD

9:55 - 10:15 am          Panel Discussion
                                  Stephanie Coulter, MD, FACC, FASE

10:15 - 10:30 am        Break
    
Session II    Non-Atherosclerotic Vascular Disease in Women

10:30 - 11:00 am        Genetics-based Personalized Medicine I
                                  AJ Marian, MD

11:00 - 11:30 am        Pulmonary Hypertension in Women: What Does the Care Team Need to Know?
                                  Ajith P. Nair, MD

11:30 - 12:00 pm        A-fib from A to Z: More Choices for Women, More Training for Us
                                  Mehdi Razavi, MD

12:00 - 12:20 pm        Panel Discussion
                                  Stephanie Coulter, MD, FACC, FASE

Lunch                         Women's Focused Research & Training Network

12:20 - 1:40 pm         Case Presentations: ASCVD Risk in the Trenches: What’s Trending in Our Community?
                                 Karla Campos, MD
                                 Case Presentations: Anticoagulants
                                 Carol Lai, MD
                                 Case Presentations: Valves
                                 Briana Costello, MD

Session III                 Treatment of Non-Coronary Vascular Disease in Women
 
1:40 - 2:10 pm          The Neglected Highway: Women & Peripheral Vascular Disease
                                David Kuten, MD
 
2:10 - 2:40 pm          Pain in the Neck? The Carotid Controversy in Women
                                Zvonimir Krajcer, MD

2:40 - 3:00 pm          Panel Discussion
                                Stephanie Coulter, MD, FACC, FASE

3:00 - 3:10 pm          Break

Session IV                 Optimizing Clinical Outcomes
    
3:10 –3:40 pm          Aortic Valve Replacement: What Really Matters for Women
                                R. David Fish, MD  

3:40 – 4:10 pm         Patients are Asking: Which Stem Cell Treatments are Ready for Prime Time?
                                Emerson Perin, MD, PhD, FACC

4:10 – 4:40 pm         Gender Differences in Transplant & MCS
                                Gabriel Loor, MD
 
4:40 – 5:00 pm         Panel Discussion
                                Stephanie Coulter, MD, FACC, FASE

5:00 – 5:15 pm         Directors Cut / Evaluation
                                Stephanie Coulter, MD, FACC, FASE

5:15 pm                    Adjourn

 

Registration

Registration fee includes all course materials, breakfast, lunch, and afternoon break. To register click here.       

Physicians (MD, DO)                                                                 $250        
Non-Physician (Nurses, Other Allied Health)                                $150        
Fellows / Residents                                                                   $75
THI/BCM/CHI SL Physicians                                                       $200
THI/BCM/CHI SL Non-Physicians (Nurses, Other Allied Health)     $100    
THI/BCM/CHI SL Fellows / Residents                                          $50

Please indicate if you need special assistance. You will be contacted by a staff member.

Cancellation Policy
All cancellations must be received by email or in writing by Monday, January 15, 2018 in order for a refund to be issued. A $50 processing fee will be assessed with each cancellation. Refunds cannot be made for those who register but do not attend the scheduled activities. Refunds will not be provided for cancellations made within 48 hours of the symposium. Texas Heart Institute reserves the right to cancel this activity if registration is deemed insufficient.

Location & Lodging

The symposium will be held in the Texas Heart Institute - The Denton A. Cooley Building located within the Texas Medical Center. The address is 6770 Bertner Avenue, Houston, Texas 77030. The meeting room, the Denton A. Cooley Auditorium, is located on the B1 level of the hospital; Green Elevators.

There are several hotels in the Texas Medical Center:

Marriott Medical Center
6580 Fannin Street
Phone: 713-796-0080   

Hilton Houston Plaza
6633 Travis Street
Phone: 713-313-4654

Holiday Inn Medical Center
6800 S. Main Street
Phone: 713-528-7744

Ground Transportation & Parking

Parking for the event is available in Garage 2 located off Holcombe and Bertner for a fee of $13. You may also valet for $14 at the front of CHI Baylor St. Luke’s Health. All registered attendees are responsible for their own parking. Taxi service to the Texas Medical Center (TMC) hotels from Hobby Airport averages $35 one way. Taxi service from Bush Intercontinental Airport averages $50 one way. Uber & Lyft is also an option. The drive to the TMC is approximately 30 minutes from Hobby Airport and approximately 45 minutes from Bush Intercontinental Airport. Rental car services are also available at both airports.